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The ergogenic effect of beta-alanine combined with sodium
bicarbonate on high-intensity swimming performance
Vitor de Salles Painelli, Hamilton Roschel, Flávia de Jesus, Craig Sale, Roger Charles Harris, Marina Yázigi Solis, Fabiana Braga Benatti,
Bruno Gualano, Antonio Herbert Lancha, Jr., and Guilherme Giannini Artioli
Abstract:We investigated the effect of beta-alanine (BA) alone (study A) and in combination with sodium bicarbonate (SB) (study B)
on 100- and 200-m swimming performance. In study A, 16 swimmers were assigned to receive either BA (3.2 g·day−1 for 1 week and
6.4 g·day−1 for 4 weeks) or placebo (PL; dextrose). At baseline and after 5 weeks of supplementation, 100- and 200-m races were
completed. In study B, 14 were assigned to receive either BA (3.2 g·day−1 for 1 week and 6.4 g·day−1 for 3 weeks) or PL. Time trials
were performed once before and twice after supplementation (with PL and SB), in a crossover fashion, providing 4 conditions:
PL-PL, PL-SB, BA-PL, and BA-SB. In study A, BA supplementation improved 100- and 200-m time-trial performance by 2.1%
(p = 0.029) and 2.0% (p = 0.0008), respectively. In study B, 200-m time-trial performance improved in all conditions, comparedwith
presupplementation, except the PL-PL condition (PL-SB, +2.3%; BA-PL, +1.5%; BA-SB, +2.13% (p< 0.05)). BA-SBwas not different from
BA-PL (p = 0.21), but the probability of a positive effect was 78.5%. In the 100-m time-trial, only a within-group effect for SB was
observed in the PL-SB (p = 0.022) and BA-SB (p = 0.051) conditions. However, 6 of 7 athletes swam faster after BA supplementation.
The probability of BA having a positive effect was 65.2%; when SB was added to BA, the probability was 71.8%. BA and SB
supplementation improved 100- and 200-m swimming performance. The coingestion of BA and SB induced a further nonsignif-
icant improvement in performance.
Key words: performance, buffer, acidosis, ergogenic aid, athlete, supplementation.
Résumé : Dans cette étude, on analyse les effets du bêta-alanine (« BA ») seul (étude A) et en combinaison avec du bicarbonate de
sodium (« SB ») (étude B) sur la performance a` la nage sur une distance de 100m et de 200m. Dans l'étude A, on répartit 16 nageurs
dans deux groupes : BA recevant 3,2 g·jour−1 durant 1 semaine; 6,4 g·jour−1 durant 4 semaines ou placebo (« PL »; dextrose). Au
début et après 5 semaines de supplémentation, les sujets participent aux épreuves de 100m et de 200m. Dans l'étude B, 14 sujets
reçoivent soit BA (3,2 g·jour−1 durant 1 semaine; 6,4 g·jour−1 durant 3 semaines) ou le PL (dextrose). Les épreuves contre-la-montre
sont réalisées une fois avant la supplémentation et deux fois après (incluant PL et SB), et ce, selon un plan croisé procurant
4 conditions : PL-PL, PL-SB, BA-PL, BA-SB. Dans l'étude A, la supplémentation en BA améliore de 2,1 % (p = 0,029) et 2,0% (p = 0,0008)
respectivement la performance aux épreuves de 100m et de 200m contre-la-montre. Dans l'étude B, a` l'épreuve de 200m contre-
la-montre, on observe une amélioration de la performance dans toutes les conditions, sauf en PL-PL comparativement a` l'épreuve
avant la supplémentation : PL-SB : +2,3 %; BA-PL : +1,5 %, BA-SB : +2,13 %; p < 0,05. On n'observe pas de différence entre BA-SB et
BA-PL (p = 0,21), mais la probabilité d'un effet positif est de 78,5 %. Dans l'épreuve de 100 m contre-la-montre, on observe
seulement un effet intragroupe de SB après PL-SB (p = 0,022) et BA-SB (p = 0,051). Toutefois, 6 athlètes sur 7 nagent plus vite après
la supplémentation en BA; la probabilité d'un effet positif de BA est de 65,2 % et celle de SB est de 71,8 % lorsqu'ajoutée a` BA. La
supplémentation en BA et en SB améliore la performance a` la nage sur des distances de 100 m et de 200 m. L'apport combiné de
BA et de SB améliore encore la performance, mais de façon non signiﬁcative. [Traduit par la rédaction]
Mots-clés : performance, tampon, acidose, facteur ergogène, athlète, supplémentation.
Introduction
Muscle acidosis is amajor cause of fatigue during high-intensity
exercise. Possible mechanisms for this include competition be-
tween hydrogen ions (H+) and calcium ions (Ca2+) at the troponin-
binding site, limiting the ability of the muscle contractile
machinery to operate effectively (Donaldson et al. 1978; Fabiato
and Fabiato 1978); impairment of energy production through the
inhibition of key glycolytic enzymes (Sutton et al. 1981); inhibition
of recovery of phosphorylcreatine (Harris et al. 1976); and disrup-
tion of its role as a temporal buffer of ADP accumulation (Sahlin
and Harris 2011). In this context, nutritional strategies capable of
increasing muscle-buffering capacity and attenuating the in-
crease in H + concentration during high-intensity exercise might
beneﬁt performance.
To date, 2 nutritional aids have been shown to reduce the rate of
intramuscular H+ accumulation: sodium bicarbonate (SB) and
beta-alanine (BA). Whereas supplementation with SB increases
the extracellular buffering capacity and the dynamic buffering
(i.e., H+ efﬂux frommuscle cells to blood) by increasing the blood
bicarbonate concentration (for a review, see Requena et al. 2005),
supplementation with BA increases intracellular buffering capac-
ity by augmenting intramuscular carnosine (-alanyl-L-histidine)
synthesis (Harris et al. 2006). In addition to the increased muscle-
buffering capacity induced by elevatedmuscle carnosine, a recent
study with human muscle ﬁbres showed that high carnosine lev-
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els can improve the Ca2+ sensitivity of the contractile apparatus
and enhance Ca2+ release from sarcoplasmic reticulumwhen Ca2+
release is inhibited, such as during fatigue (Dutka et al. 2012). This
mechanism might help to explain part of the beneﬁcial effects of
BA supplementation, with orwithout SB ingestion, that have been
reported in the literature (Sale et al. 2011).
There are various studies showing the beneﬁcial effects of both
acute and chronic SB ingestion on high-intensity exercise capacity
(McNaughton et al. 2008) and on performance in various sports,
such as judo (Artioli et al. 2007), swimming (Lindh et al. 2008), and
boxing (Siegler and Hirscher 2010). Several qualitative reviews are
available on the effects of BA on exercise performance and capac-
ity (Artioli et al. 2010; Derave et al. 2010; Sale et al. 2010). Hobson
and colleagues (2012) recently provided a quantitative review of
available studies using meta-analysis, and reported a positive ef-
fect (p = 0.002) of BA on the outcome of 57 exercise tests from
15 published papers. Much of the positive effect was explained by
signiﬁcant improvements (p = 0.013) in exercise capacity, al-
though BA did not signiﬁcantly improve exercise performance
(p = 0.204). However, it should be noted that few studies have
addressed the effect of BA on sports-speciﬁc tasks, and the ﬁnd-
ings of those that have are conﬂicting (Derave et al. 2007; Van
Thienen et al. 2009; Baguet et al. 2010; Bellinger et al. 2012;
Saunders et al. 2012).
High blood lactate (9–15 mmol·L−1) has been shown after 100-
and 200-m freestyle swimming races, suggesting that acidosis is a
key feature of short-distance swimming events (Bonifazi et al.
1993). Therefore, it seems reasonable to expect that athletes en-
gaged in these events will beneﬁt from an enhanced ability to
buffer reductions in intracellular pH. A combination of strategies
capable of increasing intracellular (with BA supplementation) and
extracellular and dynamic buffering capacity (with SB supplemen-
tation) could further enhance the ability of the muscle to buffer
H+. Also, the recently demonstrated effect of carnosine on calcium
sensitivity (Dutka et al. 2012) could provide an additional theoretic
mechanism for the additive ergogenic effect of BA and SB.
Some studies have examined the ergogenic potential of SB on
short-distance swimming performance (i.e., 100 and 200 m or 100
and 200 yards) and interval swimming performance (Gao et al.
1988; Pierce et al. 1992; Lindh et al. 2008; Pruscino et al. 2008;
Siegler and Hirscher 2010; Joyce et al. 2012). However, results are
quite conﬂicting; some studies reported no effect of SB on time-
trial performance (Pierce et al. 1992; Pruscino et al. 2008; Joyce
et al. 2012), one reported a positive effect on swimming trials
(Lindh et al. 2008), and others reported improved interval swim-
ming performance (Gao et al. 1988; Siegler and Hirscher 2010).
However, no study has yet investigated the effects of BA supple-
mentation on swimming performance. Likewise, the potential for
coingestion of BA and SB to further improve swimming perfor-
mance, compared with either BA or SB alone, has not been stud-
ied. Existing studies on the combined effects of BA and SB on
exercise capacity (Sale et al. 2011) and performance (Bellinger et al.
2012) are equivocal, and further information is required from
well-controlled exercise performance studies. Therefore, we per-
formed 2 independent studies aimed at examining the effect of BA
supplementation alone (study A) and in combination with SB sup-
plementation (study B) on high-intensity swimming performance
(i.e., 100- and 200-m races).
Materials and methods
Study A: Effects of BA on swimming performance
Participants
Eighteen junior-standard swimmers (12 male, 6 female) volun-
teered to participate in the study. Participant characteristics are
presented in Table 1. All swimmerswerewell-trained athletes who
were actively participating in state-level ofﬁcial competitions at
the time of data collection. All athletes were involved in a regular
training program that focused on 100- and 200-m distance train-
ing. The periodization phase was the same during the course of
the study, and training regimens consisted of 6 × 1.5 h pool-based
and 2 × 1 h land-based training sessions per week. Participants had
not consumed creatine in the 3months prior to the study or BA in
the 6 months prior to the study. All participants were fully in-
formed of any risks and discomforts associated with the study,
and all gave their written informed consent. The study was ap-
proved by the institution's Ethical Advisory Committee.
Experimental design and dietary supplementation
A randomized, double-blind, placebo-controlled, parallel-group
study was conducted. The randomization was stratiﬁed by gender
and by individual best time in the 200-m race.
The athletes were assigned to receive either BA (n = 9) or placebo
(PL; n = 9). However, 2 volunteers from the PL group dropped out
before completing the study. Athletes in the BA group received
3.2 g·day−1 of BA (CarnoSyn, Compound Solutions Inc., Vista,
Calif., USA) during the ﬁrst week (800 mg gelatin capsules, taken
4 times per day) and 6.4 g·day−1 during the subsequent 4 weeks
(2 × 800 mg gelatin capsules, taken 4 times per day). Athletes in
the PL group received the exact same amount of placebo (i.e.,
dextrose), which was given as identical capsules (Ethika Inc., Sao
Paulo, Brazil). Carboxymethyl cellulose was added to both BA and
dextrose capsules to slow the absorption of BA and minimize
paraesthesia.
Figure 1 illustrates the experimental design. Participants under-
went the same experimental procedures on 2 different occasions,
5 weeks apart. The trials were completed at baseline (PRE) and
after 5 weeks of supplementation (POST). In each trial, the ath-
lete's performance was assessed with 2 simulated swimming time
trials (i.e., 100- and 200-m freestyle races).
Simulated swimming time trials
All simulated swimming time trials took place in the same
swimming pool (2 m deep × 25 m long × 20 m wide) at the same
time of day (1500–1700 h). The athletes were familiar with com-
peting over the set distances and performed each race in ability-
matched pairs, as assigned by their coach. This procedure was
adopted to introduce a competitive element to the protocol,
which helps to make the simulation closer to a real competitive
situation (Lindh et al. 2008). The order of racingwas kept the same
in the PRE and POST trials. Each pair completed a standardized
warm-up prior to each trial. Ten minutes after the warm-up, the
Table 1. Participant characteristics in studies A and B.
Study A Study B
Variable BA (n = 9) PL (n = 7) BA (n = 7) PL (n = 7)
Age (y) 18.62±1.99 20.16±5.91 20.71±3.35 18.71±2.75
Height (m) 1.80±0.05 1.77±0.06 1.83±0.05 1.79±0.06
Body mass (kg) 69.82±10.90 68.43±9.67 71.92±15.15 67.82±8.00
200-m TT performance (s) 139.13±16.24 144.28±18.19 131.62±8.84 137.38±9.79
100-m TT performance (s) 62.15±7.26 64.79±8.51 60.00±4.31 63.26±5.55
Note: No differences between groups in the 2 studies. BA, beta-alanine; PL, placebo; TT, time trial.
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pairs performed the 200-m freestyle time-trial performance. After
the 200-m trial, the athletes recovered for 30 min before the same
pairs performed the 100-m freestyle time-trial performance. All
races started with the athletes diving off diving blocks and were
timed using an electronic timing system (Omega Swiss Timing,
Bern, Switzerland).
Food intake assessment
To control for intervening variables, food intake was assessed
during the supplementation period bymeans of three 24-h dietary
recalls undertaken on separate days (2 weekdays and 1 weekend
day), with the aid of a visual photo album of real-sized foods
and portions. The 24-h dietary recall consisted of listing the foods
and beverages consumed during the 24 h before the assessment.
Nutritional supplements were also recorded. Energy and macro-
nutrient intake were analysed with Virtual Nutri software (Sao
Paulo, Brazil).
Study B: Effects of the coingestion of BS and SB on
swimming performance
Participants
Fourteen junior-standard swimmers (7 male, 7 female), not en-
gaged in studyA, volunteered forparticipation in this study (athletes'
main characteristics are presented in Table 1). The periodization
phase was the same during the course of the study, and training
regimens consisted of 8 × 2.5-h pool-based and 3 × 1.5-h land-based
training sessions a week. Exclusion criteria, randomization and
blinding procedures, and dietary assessment and performance
tests were identical to those described in study A. All participants
were fully informed of any risks and discomforts associated with
the study, and all gave their written informed consent. The study
was approved by the institution's Ethical Advisory Committee.
Experimental design
The experimental design (Fig. 1) was adapted from Sale et al.
(2011). The performance tests were identical to those applied in
study A. The ﬁrst trial (PRE) was completed prior to the supple-
mentation period. The athletes were then randomly assigned to
receive either BA (n = 7) or PL (n = 7), and were supplemented for
4 weeks and 4 days. The BA group received 3.2 g·day−1 of BA
(CarnoSyn, Compound Solutions Inc.) during the ﬁrst week
(800 mg gelatin capsules, taken 4 times per day) and 6.4 g·day−1
during the subsequent 3 weeks and 4 days (2 × 800 mg gelatins
capsules, taken 4 times per day). Athletes in the PL group received
the exact same amount of placebo (i.e., dextrose), whichwas given
as identical capsules (Ethika Inc.). Carboxymethyl cellulose was
added to both BA and dextrose capsules to slow the absorption of
BA and minimize paraesthesia.
After 4 weeks of BA or PL supplementation, the athletes acutely
ingested either SB (0.3 g·kg−1 body weight) or placebo (same dose
of dextrose) in a crossover fashion (POST1 and POST2 assessments
(POST1 and POST2, the ﬁrst and second assessment of swimming
performance, respectively, after the supplementation begun)).
There was a 4-day interval between trials, during which the par-
ticipants continued the BA or PL supplementation. SB and placebo
were acutely consumed over a 10-min period, with 500mL of plain
water, commencing 90 min prior to the start of the trials. This
design allowed for 4 experimental conditions: PL-PL, PL-SB, BA-PL,
and BA-SB.
Statistical analysis
In both studies, unpaired t tests were used to compare perfor-
mance, food intake, and participant characteristics between
groups at the PRE trial. Swimming performance was tested with
repeated-measures mixed models, followed by single-degree-of-
freedom contrast analysis. In study A, the absolute changes (i.e.,
POST-PRE) in performance were compared in the experimental
groups using an unpaired t test. In study B, absolute changes were
compared in the experimental conditions with a 1-way analysis of
variance, followed by a Tukey's post hoc test. Additionally, a
magnitude-based inference was conducted, following the recom-
mendations of Batterham and Hopkins (2006), to detect small
effects of practical importance in an applied setting. This estab-
lishes the likelihood (in percentage terms) of each experimental
manipulation having a positive, trivial, or negative effect. All
Fig. 1. Experimental design of studies A (top panel) and B (bottom panel). BA, beta-alanine; SB, sodium bicarbonate; suppl., supplementation;
POST1, performance assessment immediately after the 4 weeks of supplementation; POST2, performance assessment immediately after the
4 weeks and 4 days of supplementation.
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other analyses were conducted using SAS software, version 9.2.
The signiﬁcance level was set at p < 0.05.
Results
Study A
No between-group differences were observed prior to supple-
mentation (PRE) for the 100- and 200-m freestyle races (Table 1).
In the 100-m trial, mixed-model analysis revealed a trend to-
ward a signiﬁcant effect of BA supplementation on the time-trial
performance (interaction effect, F = 3.75; p = 0.07) (Fig. 2A). Also,
contrast analysis revealed a signiﬁcant within-group effect after
BA supplementation (p = 0.029) (Fig. 2A). Absolute changes in
performance in the BA group, compared with the PL group, ap-
proached a statistically signiﬁcant difference in the 100-m race
(p = 0.07) (Fig. 2B). Individual data show that all 9 athletes swam
faster after BA supplementation (average change, –2.1%), whereas
only 4 of 7 in the PL group swam faster in the 100-m race (average
change, +0.3%) (Table 2).
In the 200-m trial, a signiﬁcant interaction effect was observed
in the mixed-model analysis (F = 7.59; p = 0.015) (Fig. 2C). Also,
contrast analysis revealed a signiﬁcant within-subject effect in the
BA group (p = 0.0008) (Fig. 2C). Absolute changes in performance
observed in the BA groupwere statistically different from those in
the PL group in the 200-m race (p = 0.002) (Fig. 2D). Individual data
showed that 8 of 9 athletes swam faster in the BA group (average
change, –2.0%), whereas 4 of 7 swam faster in the PL group (aver-
age change, –0.1%) (Table 2).
Magnitude-based inference analysis revealed that the positive
performance changes after BA supplementation in the 100- and
200-m trials were approximately 96% and 99%, respectively
(Table 3).
Food intake
The intake of energy (BA, 3499 ± 1327 kcal; PL, 3335 ± 1035 kcal;
p = 0.80), carbohydrate (BA, 52.8% ± 5.9%; PL, 50.4% ± 8.2%; p = 0.55),
lipid (BA, 30.8% ± 7.7%; PL, 29.8% ± 5.2%; p = 0.77), and protein (BA,
16.7% ± 2.3%; PL, 19.9% ± 6.2%; p = 0.23) did not signiﬁcantly differ
within or between groups.
Study B
At PRE, there were no signiﬁcant differences between the BA
and PL groups in either 100- or 200-m freestyle time-trial perfor-
mance (Table 1).
100-m swimming performance
In the 100-m time trial, the mixed-model analysis showed no
interaction effect (F = 1.36; p = 0.28). Contrast analysis revealed
signiﬁcant within-group effects when SB was ingested (i.e., in the
PL-SB and BA-SB conditions; p = 0.022 and p = 0.051, respectively),
Fig. 2. Time-trial performance (A, C) and absolute changes in time-trial performance (B, D) for the beta-alanine (BA) and placebo (PL; dextrose)
conditions in both 100-m and 200-m races (study A). ns, not signiﬁcant. *, p = 0.029 for within-group effect; †, p = 0.0008 for within-group effect.
Table 2. Individual time-trial performance (in seconds) in the 100-
and 200-m swimming races (study A).
Athlete
no.
Placebo Athlete
no.
Beta-alanine
PRE POST PRE POST
100-m time trial
1 59.97 59.28 8 53.58 52.62
2 55.85 55.22 9 70.12 69.50
3 81.21 83.82 10 76.03 75.89
4 63.60 62.16 11 61.87 61.09
5 61.87 64.77 12 64.16 59.47
6 60.46 60.84 13 57.43 56.16
7 70.59 69.30 14 56.96 56.45
— — — 15 56.28 55.56
— — — 16 63.19 61.20
Mean ± SD 64.79±8.52 65.06±9.37 62.18±7.23 60.88±7.42
200-m time trial
1 132.19 129.60 8 118.22 115.05
2 122.35 123.60 9 162.08 158.57
3 175.75 177.32 10 165.94 162.87
4 142.97 139.78 11 139.86 135.59
5 154.38 158.06 12 145.00 145.00
6 130.10 130.06 13 130.88 128.00
7 152.23 151.21 14 129.12 126.21
— — — 15 124.25 123.65
— — — 16 136.88 132.00
Mean ± SD 144.3±18.2 144.2±19.1 139.1±16.2 136.3±16.1
Note: PRE, baseline; POST, after 5 weeks of supplementation.
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but no effect was observed in the BA-PL condition (p = 0.49) (Fig. 3A).
The combination of BA plus SB did not elicit further improve-
ments in the 100-m performance, compared with BA alone
(p = 0.29) (Fig. 3A). However, the likelihood of BA having a positive
effect on performance was 65%, and the likelihood of SB exert-
ing additive effects to BA was 72% (Table 3).
Absolute change analysis revealed no differences in the 4 con-
ditions (F = 2.01; p = 0.14) (Fig. 3B). Two of the 7 athletes swam faster
after placebo ingestion (i.e., PL-PL condition; average change,
+1.1%;  mean time, +0.67 ± 2.77 s) than before supplementation.
In contrast, 100-m performance improved in 6 of the 7 athletes
after acute SB supplementation (i.e., PL-SB condition; average
change, –2.6%;  mean time, –1.70 ± 2.07 s) and after chronic BA
supplementation (i.e., BA-PL condition; average change, –1.4%;
mean time, –0.84 ± 1.47 s). All 7 athletes were faster after chronic
BA combined with acute SB supplementation (average change,
–2.8%;  mean time, –1.59 ± 1.71 s) than before supplementation.
All 7 athletes showed further improvement in the 100-m perfor-
mance after acute SB supplementation combinedwith chronic BA
supplementation (BA-SB), compared with placebo (BA-PL) (average
change, –1.4%; mean time, –0.76 ± 0.43 s). Table 4 presents data
for the individual athletes.
200-m swimming performance
There was a signiﬁcant improvement in the 200-m time-trial per-
formance after chronic supplementation with BA, after acute inges-
tion of SB, and after the combination of these 2 (interaction effect,
F = 5.17; p = 0.024) (Fig. 3C). According to the contrast analysis, BA
supplementation (i.e., BA-PL condition) tended to improve 200-m
performance (p = 0.06), compared with the PRE performance
(Fig. 3C), whereas both PL-SB and BA-SB supplementation signiﬁ-
cantly improved 200-m performance (p = 0.0001 and p < 0.0001, re-
spectively) (Fig. 3C). The combination of BA plus SB did not elicit
further signiﬁcant improvements in the 200-m performance, com-
pared with BA alone (p = 0.21) (Fig. 3C). However, the likelihood
of BA having a positive effect on the 200-m performance was
92%, and the likelihood of SB having additive effects to BA
was 78% (Table 3).
Absolute change analysis revealed that the BA-PL, PL-SB, and
BA-SB conditions yielded greater performance improvements
than PL-PL (F = 8.5; p = 0.001), although no differences were ob-
served between conditions (Fig. 3D). Three of the 7 athletes swam
faster after placebo ingestion (i.e., PL-PL condition; average
change, +0.9%;mean time, +1.31 ± 2.77 s) than before supplemen-
tation. All 7 athletes showed improved 200-m performance after
acute SB supplementation (i.e., PL-SB condition); average change,
–2.3%;  mean time, –3.29 ± 3.29 s) and after chronic BA supple-
mentation (i.e., BA-PL condition; average change, –1.5%;  mean
time, –1.97 ± 1.01 s). All 7 athletes were also faster after chronic BA
combined with acute SB supplementation (average change,
–2.13%; mean time, 2.78 ± 0.82 s) than before supplementation.
Additionally, all 7 athletes showed further improvements in the
200-m performance when acute SB supplementation followed
chronic BA supplementation (BA-SB), compared with placebo
(BA-PL) (average change, –0.63%;  mean time, –1.18 ± 0.62 s).
Table 4 presents data for the individual athletes.
Food intake analysis
The intake of energy (BA, 3418 ± 822 kcal; PL, 3219 ± 794 kcal;
p = 0.66), carbohydrate (BA, 57.1% ± 6.8%; PL, 53.2% ± 5.6%; p = 0.29),
lipid (BA, 24.2% ± 4.5%; PL, 26.3% ± 6.4%; p = 0.51), and protein (BA,
18.5% ± 6.8%; PL, 20.4% ± 3.8%; p = 0.56) did not signiﬁcantly differ
within or between groups.
Side effects and blinding efficacy
In study A, 4 of 9 subjects reported mild paraesthesia with BA
supplementation; in study B, 4 of 7 subjects reported the same
symptoms. None of the subjects in study B reported severe gastro-
intestinal symptoms related to SB ingestion, but all of them expe-
rienced eructation with SB supplementation. In study A, 7 of
16 subjects successfully predicted the substance ingested (Fischer's
exact test, p = 0.61). In study B, 6 of 14 subjects successfully pre-
dicted BA or PL during the 4 weeks (Fischer's exact test, p = 0.59),
whereas 8 of 14 subjects successfully predicted SB or PL after acute
ingestion (Fischer's exact test, p = 0.59).
Discussion
To our knowledge, this is the ﬁrst study to examine the ergo-
genic effects of BA supplementation on swimming performance.
Furthermore, this is one of the few studies to examine the effects
of BA, with or without SB supplementation, in well-trained com-
petitive athletes.
Our main ﬁnding is that 4 and 5 weeks of BA supplementation
effectively improved the 200-m freestyle swimming performance
of trained athletes, and tended to improve the 100-m perfor-
mance. Although the effect of BA on the 100-m performance did
not reach statistical signiﬁcance, 15 of 16 athletes (all 9 in study A
and 6 of 7 in study B) performed better after BA supplementation
than before, which is likely to be relevant in real competitive
settings (probability of positive effect was 96.2% in study A and
65.2% in study B). Combining data from the 2 studies (while noting
the slightly shorter supplementation period in study B), we esti-
mate that the 100-m swim time improved with 4–5 weeks of BA
supplementation by –1.08 ± 1.39 s, compared with a presupple-
mentation time of 61.22 ± 6.06 s, in contrast to a mean change in
the combined placebo group of +0.46 ± 2.26 s. Similarly, the com-
bined 200-m swim data allowed us to estimate an improvement of
–2.28 ± 1.47 s after 4–5 weeks of BA supplementation, in contrast
to amean change in the combined placebo group of +0.63 ± 2.60 s.
It is interesting to note that BA supplementationwas somewhat
more effective in study A than in study B, especially for the 100-m
time trials. The most likely explanation for this relates to the
statistical power of the 2 studies; although study A assessed 3
more athletes than study B, the number of levels in the statistical
analysis in study B was considerably higher, which certainly hin-
dered our ability to detect the slight, though meaningful, im-
provements in performance elicited with BA. To overcome this
Table 3. Magnitude-based inference analysis of results
from studies A and B.
Comparators
Probability
of being
positive, %
Probability
of being
trivial, %
Probability
of being
negative, %
Study A (100 m)
BA vs. PRE 96.2 3.3 0.5
PL vs. PRE 18.0 34.4 47.6
Study A (200 m)
BA vs. PRE 99.2 0.7 0.1
PL vs. PRE 32.1 40.1 27.8
Study B (100 m)
BA vs. PRE 65.2 25.9 8.9
SB vs. PRE 97.0 2.6 0.4
BA-SB vs. PRE 93.6 5.5 0.9
PL vs. PRE 12.6 30.0 57.4
BA-SB vs. BA 71.8 21.7 6.5
Study B (200 m)
BA vs. PRE 92.3 6.4 1.3
SB vs. PRE 100 0.0 0.0
BA-SB vs. PRE 100 0.0 0.0
PL vs. PRE 2.6 11.0 86.4
BA-SB vs. BA 78.5 16.8 4.7
Note:All probabilities refer to the POST trial (after supplemen-
tation) vs. the PRE trial (baseline), except BA-SB vs. BA, which
refers to the addition of sodium bicarbonate (SB), compared with
beta-alanine (BA) alone.
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issue, we used a magnitude-based inference analysis, which may
be a more appropriate approach in this type of study (Batterham
and Hopkins 2006). In contrast to the 100-m time trials, the ergo-
genic effect of BA on the 200-m performance was more consistent
in the 2 studies. This can be explained by the duration of the
200-m trial, which falls into the range that gets more beneﬁt from
BA supplementation (i.e., exercise lasting 60 to 240 s) (Hobson
et al. 2012). Alternatively, it could be argued that the higher train-
ing volume and the better competitive indexes of athletes in
study B hindered the effect of BA supplementation. This possibil-
ity cannot be ruled out because there is indirect evidence in the
literature indicating that the putative increase in muscle-
buffering capacity inducedwith high-volume, high-intensity long-
term training regimens diminishes the importance of the BA-
induced increase in muscle carnosine (Bellinger et al. 2012).
Study B indicates that SB was also effective in improving both
the 100- and 200-m swimming performance, and to a similar ex-
tent as that achieved with BA. Moreover, acute SB decreased the
swim time in athletes already supplemented with BA by a further
–0.76 ± 0.43 s (71.2% likelihood of a positive effect) and –1.18 ± 0.62 s
(78.5% likelihood of a positive effect) over the 100-m and 200-m
trials, respectively. The combined effect of BA + SB supplementa-
tionwere –1.59 (±1.71) s and –2.78 (±0.82) s, respectively. Our results
are in accordance with those of Sale et al. 2011, which indicated
that the coingestion of BA plus SB, compared with either one
alone, led to a 4.1% increase in time to exhaustion, which related
to a 69% probability that this is a meaningful difference in exer-
cise capacity. Taken together, these 2 studies suggest a slight but
probably important additive effect of BA and SB. Further studies
are needed to examine whether or not different dosing regimens
Fig. 3. Time-trial performance (A, C) and absolute changes in time-trial performance (B, D) for the beta-alanine (BA) and placebo (PL)
conditions in both 100- and 200-m races before and after the acute ingestion of sodium bicarbonate (SB) and placebo (study B). ns, not
signiﬁcant. *, Signiﬁcantly different from baseline (p < 0.05 for within-group effect); p values that tended to be signiﬁcantly different from
baseline are displayed in the ﬁgure.
Table 4. Individual time-trial performance (in seconds) in the 100- and 200-m swimming races
(study B).
Placebo condition BA condition
Athlete no. Baseline PL-PL PL-SB Athlete no. Baseline BA-PL BA-SB
100-m time trial
17 65.45 70.91 65.29 24 55.73 55.76 54.06
18 65.85 61.99 60.59 25 55.82 55.78 54.79
19 57.94 59.81 55.63 26 56.91 56.47 56.37
20 58.33 58.97 58.84 27 64.38 64.16 63.43
21 56.47 56.47 56.17 28 63.62 63.28 62.72
22 69.28 68.78 68.41 29 65.51 64.78 64.34
23 69.45 70.59 66.01 30 58.07 53.94 52.63
Mean±SD 63.25±5.55 63.93±6.02 61.56±5.05 60.01±4.31 59.17±4.67 58.33±4.97
200-m time trial
17 150.09 152.88 148.32 24 123.79 121.41 120.31
18 138.18 137.44 136.23 25 120.45 119.71 118.37
19 126.81 126.12 123.41 26 134.86 133.19 131.72
20 127.78 127.35 127.18 27 139.02 138.15 137.29
21 128.73 129.54 126.77 28 138.87 135.26 135.01
22 147.94 148.44 146.90 29 141.26 140.19 139.22
23 142.19 149.14 139.10 30 123.12 122.22 119.95
Mean±SD 137.4±9.8 138.7±11.4 135.4±10.0 131.6±8.8 130.0±8.6 128.8±9.0
Note: BA, beta-alanine; PL, placebo; SB, sodium bicarbonate.
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of BA (e.g., for periods longer than 4 or 5weeks, which could result
in highermuscle carnosine accretion (Hill et al. 2007)) and SB (e.g.,
chronic supplementation) display more evident additive ergo-
genic effects.
More and more studies have shown that BA supplementation
can improve high-intensity exercise capacity (Hobson et al. 2012),
but fewer studies have examined the effect on exercise perfor-
mance. Exercise performance studies are required to provide di-
rect evidence of the efﬁcacy of BA supplementation as an
ergogenic aid in real sports settings. The few existing studies in-
volving the application of BA to relevant sports activities have
revealed a potential ergogenic effect in the ﬁnal sprint of a cycling
race (Van Thienen et al. 2009) and in rowing (Baguet et al. 2010),
but not in a soccer-speciﬁc test (Saunders et al. 2012) or 400-m
running trials (Derave et al. 2007). Indeed, further investigations
are warranted to determine which sports could theoretically ben-
eﬁt from the ergogenic effect of BA (e.g., 400-m swimming races,
800-m running races, team sports, and combat sports).
It is important to emphasize that most investigations involving
BA supplementation have enrolled physically active individuals,
rather than well-trained athletes (Hill et al. 2007; Stout et al. 2007;
Zoeller et al. 2007; Smith et al. 2009). Despite the methodologic
constraints inherent in studies involving athletes (e.g., reduced
sample size, competition schedule constraints, inability to per-
form invasive assessments), they are important to substantiate
the efﬁcacy of nutritional aids in sports. In this sense, our inves-
tigation corroborates the ergogenic effects of BA. In fact, by exam-
ining the intraindividual variances in the most recent Brazilian
national-level 100- and 200-m freestyle competitions (i.e., the same
competitive level as the athletes enrolled in our study), we ob-
served that the improvements seenwith both BA and SB aremuch
greater than the normal variance of the real competition (normal
variance, 0.4% for 100-m and 0.01% for 200-m trials, comparedwith
improvements ranging from 1.4% to 2.8% after supplementation).
This strengthens the concept that both strategies can provide
meaningful advantages in actual competitions. Furthermore, con-
sidering the 100- and 200-m racing times of men and women
competing at the semiﬁnals and ﬁnals in the 2012 Olympic Games
in London, the absolute improvements promoted by both BA
(–1.28 s over 100 m and –1.60 s over 200 m) and SB (–1.69 s over
100 m and 1.97 s over 200 m) would have elevated the sixth-place
athlete to ﬁrst place in most events. Hence, the improvements
observed in our investigation could represent a useful competi-
tive advantage in the “real-world” scenario. However, it is impor-
tant to highlight the fact that our athletes had noOlympic indexes
at the time of data collection, although all of them were well
trained. Thus, caution should be exercised when extrapolating
these ﬁndings to top-level elite athletes.
An important limitation of this study is the lack of muscle and
blood analyses to conﬁrm the ability of BA to increase muscle
carnosine and of SB to increase blood bicarbonate. However, be-
cause only well-trained competitive athletes volunteered for the
investigation, data collection had to include only minimally inva-
sive procedures. Despite the lack of these measurements, every
human study using 1.6 to 6.4 g·day−1 of BA for 4 weeks or longer
has found increases of >40% in muscle carnosine (Stellingwerff
et al. 2012). Likewise, many studies have consistently demon-
strated that acute ingestion of 300 mg·kg−1 of SB results in a sig-
niﬁcant increase in blood bicarbonate concentration and pH
(Requena et al. 2005). Therefore, the supplementation protocols
used for both BA and SB in our study are very likely to have
promoted increased muscle carnosine and blood bicarbonate, re-
spectively, which minimizes the weight of these lacking data.
Finally, it is important to note that more than 50% of the ath-
letes ingesting BA reported mild paraesthesia, which is a symp-
tom commonly described when 1600 mg of BA in powder is
acutely ingested (Harris et al. 2006; Decombaz et al. 2011). The
same symptoms are not observed when 1600mg of BA is provided
in controlled-release tablets (Stellingwerff et al. 2012), suggesting
that the strategy adopted in our study to slow the absorption of
BA (i.e., the addition of carboxymethyl cellulose to the gelatin
capsules) was only partially successful in preventing paraesthesia.
Despite this, our data show that the athletes were not able to
correctly guess the substance that they were taking, which sug-
gests that the blinding remained intact.
In conclusion, BA and SB supplementation improved the 200-m
freestyle swimming performance in highly trained athletes, and
tended to improve the 100-m performance. The coingestion of BA
and SB further increased the 200-m time-trial performance by
–1.18 s and the 100-m time-trial performance by –0.76 s, compared
with BA alone, which makes the effect of supplementation, re-
spectively, 80% and 70% likely to be meaningful. Future stud-
ies involving trained athletes are warranted to investigate the
effect of BA, with and without SB, in the various sports in which
performance is limited by acidosis.
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